Print

Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study  
12/30/2010 6:42:31 AM

MDS Beacon -- Preliminary results of a Phase 2 trial show that the experimental drug panobinostat has little activity in patients with relapsed and resistant myelodysplastic syndromes.
//-->